.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Lunch-Symposium

Cerus Europe B.V.: INTERCEPT Blood System – der aktuelle Standard für die sichere Blutversorgung

Appointment

Date: 22/09/2022

Time: 12:15 – 13:15

Location / Stream:

Johann Wenzel Stamitz

Vorsitz (IND)

Description

Sponsor

Programme

12:15 – 12:20 5 Min. 0 Min.
Sonstiges
Introduction
Prof. Torsten Tonn (Dresden / DE)
12:20 – 12:35 15 Min. 0 Min.
Vortrag IND (online)
US decision to a fully pathogen reduced Intercept platelet inventory
Dr. Eric A. Gehrie (Washington, DC / US)
12:35 – 12:50 15 Min. 0 Min.
Vortrag IND
The French experience: evolution of the platelet production and patient outcomes with adoption of pathogen inactivation
Catherine Humbrecht (Straßburg / FR)
12:50 – 13:00 10 Min. 0 Min.
Vortrag IND
Reasons for implementation of PI and validation data from Berlin
Dr. Thilo Bartolmäs (Berlin / DE)
13:00 – 13:15 0 Min. 15 Min.
Sonstiges
Discussion